← All companies
OSRH
OSR Health, Inc.
$0.05
+0.01 +34.29%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.65M
Revenue (TTM)
$2.63M
Net income (TTM)
-$19.1M
EPS (TTM)
$0.16
P/E ratio
0.3
Dividend yield
—
Free cash flow
—
Cash
$1.57M
Total assets
$172M
Gross margin
22.2%
52-week range
$0.04 – $0.05
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 31, 2026
8-K
Amended charter or bylaws
Jun 17, 2026
8-K
Other events
Jun 11, 2026
8-K
Entered a material agreement
Jun 2, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
8-K/A
AMENDMENT NO. 1 TO FORM 8-K
May 6, 2026
8-K
Entered a material agreement; Regulation FD disclosure
Apr 30, 2026
8-K
Director or officer change
Apr 22, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure
Apr 9, 2026
8-K/A
AMENDMENT NO. 1 TO FORM 8-K
Apr 3, 2026
8-K
Entered a material agreement
Apr 2, 2026
10-K
Fiscal year ended 2025-12-31
Mar 31, 2026
8-K
Regulation FD disclosure
Mar 16, 2026
8-K
Delisting notice or listing-rule failure
Mar 10, 2026
8-K
Completed an acquisition or disposition; Regulation FD disclosure
Jan 27, 2026
8-K
Entered a material agreement; Regulation FD disclosure
Jan 14, 2026
8-K
Regulation FD disclosure; Other events
Nov 25, 2025
10-Q
Quarter ended 2025-09-30
Nov 12, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Oct 16, 2025
8-K
Shareholder vote results
Sep 23, 2025
8-K
Delisting notice or listing-rule failure
Sep 9, 2025
8-K
Other events
Sep 9, 2025
8-K
Entered a material agreement
Aug 20, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Regulation FD disclosure
Aug 6, 2025
8-K
Other events
Jul 25, 2025
8-K
Director or officer change
Jul 2, 2025
10-Q
Quarter ended 2025-03-31
May 20, 2025
8-K
Entered a material agreement
May 12, 2025
8-K/A
AMENDMENT NO. 1 TO FORM 8-K
Apr 22, 2025
10-K
Fiscal year ended 2024-12-31
Apr 22, 2025
8-K
Director or officer change
Mar 25, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Feb 28, 2025
8-K
Entered a material agreement; Completed an acquisition or disposition; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.06
Feb 21, 2025
8-K
Other events
Feb 18, 2025
8-K
Amended charter or bylaws; Shareholder vote results; Other events
Feb 13, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Jan 23, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Jan 10, 2025
8-K
Entered a material agreement
Dec 23, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024